Introduction
============

The use of mechanical ventilation for acute respiratory failure (ARF) in patients with cystic fibrosis (CF) has long been discouraged because of a poor outcome in this group of patients. However, new insights into ventilatory strategies and a better life expectancy *per se*in CF patients necessitate regular reevaluation of this attitude. The most recent studies report a mortality in adult CF patients requiring mechanical ventilation that varies widely between 45% and 80%. Results in children are reported as more favourable, but little is known about the long-term pulmonary outcome of children with CF who required mechanical ventilation for ARF already at a young age.

Objectives
==========

The goals of this study were threefold: to assess outcome of assisted ventilation in CF patients with ARF; to identify risk factors associated with a poor outcome; and to analyse whether children with CF who required mechanical ventilation for ARF at a young age had more pulmonary and CF-related complications later in life compared with unventilated CF controls.

Design
======

A retrospective cohort study.

Setting
=======

The study was performed at the University Medical Centre Utrecht (Utrecht, The Netherlands) and at the Leyenburg Hospital (The Hague, The Netherlands). These centres care for approximately one-half of the Dutch CF population.

Methods
=======

Medical charts were reviewed of all CF patients who had been admitted to the intensive care unit for ARF between January 1990 and August 2003. ARF was defined as a respiratory deterioration requiring assisted ventilation, due to an acute illness in a previously stable patient. Assisted ventilation could be either non-invasive or invasive. Patients with chronic respiratory failure with a slow progressive decline in lung function were not included. To identify risk factors for mortality, the following data were recorded: demographic data, body mass index, spirometric data, mode of ventilation, sputum microbiology, history of hemoptysis or pneumothorax, the presence of CF-related diabetes and the presence of CF-related liver disease.

To analyse long-term outcome in children who survived assisted ventilation for ARF, all unventilated age-matched and gender-matched CF controls were identified. Lung function and the presence of CF-related complications 5 years after admission to the ICU were compared.

Results
=======

Thirty-two CF patients were included, five children (aged 2--18 months) and 27 adults (aged 15 years and older). All children and 30% of the adults survived.

In the total population, age was a statistically significant risk factor for poor outcome (*P*= 0.03). In the adult population, none of the demographic and clinical data could predict outcome significantly. In patients who had an episode of ARF in childhood, clinical course and lung function 5 years after assisted ventilation was not significantly different compared with their controls.

Conclusions
===========

CF patients aged 2 years or younger who are ventilated because of ARF have a good prognosis and assisted ventilation does not seem to affect lung function or development of CF-related complications later in their lives. ARF in adult CF patients still is associated with a high mortality. Risk factors for poor outcome could not be identified.
